The Falsified Medicines Directive requires unique identifiers and anti-tamper devices on every Rx pack sold in Europe; good distribution practice requires auditable chain-of-custody; the ESPR begins to touch medical device packaging. Fidaty brings them together with a serial-level DPP, verified-actor custody transfers and diversion detection.
Serial
Granularity
Per-pack DPP
GS1
Data Matrix
GTIN + serial + batch + expiry
GDP
Chain-of-custody
Verified actors only
2D
Scan workflow
Any smartphone verify
Anti-counterfeit pharma already has FMD. What's missing is a downstream-usable record per pack that pharmacists, hospitals, wholesalers and regulators all read from one source. Fidaty binds the FMD serial to a Fidaty DPP and adds verified chain-of-custody with diversion detection — without replacing the EMVS infrastructure.
Every prescription pack already carries a GS1 Data Matrix with GTIN, serial, batch and expiry. Fidaty creates an on-chain DPP keyed to that serial — no re-printing, no workflow change at the line, all additive.
Fidaty reads the existing FMD identifier and mints a DPP bound to the serial. No additional artwork change; the same scan opens the DPP.
Aggregation captured per GS1 SSCC logic: pack in carton, carton on pallet. Full disaggregation on goods-in scans downstream.
Which anti-tamper solution is applied (shrink wrap, perforation, hologram) recorded per SKU. If broken, the consumer / pharmacist is warned via DPP scan.
Good Distribution Practice requires auditable custody across wholesaler, 3PL, pharmacy. Fidaty's chain-of-custody module only accepts scans from pre-verified actors, cryptographically signed, and stores the full event trail for the regulator.
Pharmaceutical wholesaler licenses (GDP authorisation number) verified before an actor can appear in a custody chain. No unknown parties in the trail.
Integration with IoT temperature loggers; Fidaty records the temperature envelope per custody segment. Breach → DPP flag; receiver decides to accept or reject.
Regulator or MAH requests "where did batch 2417 go?" — Fidaty replays the custody tree down to pharmacy-level in seconds.
Diversion (legitimate product, illegitimate market) costs pharma ~$150 bn / yr globally. Fidaty detects diversion from scan patterns and allows instant revocation when a serial escapes its authorised channel.
For high-value Rx with NFC tags: monotonically-increasing counter on every tap; cloned tags replay old counters and fail verification.
Same serial scanned on two continents within hours, hundreds of scans from one IP, scans outside authorised markets — all flagged automatically.
MAH identifies a diverted batch → revoke on-chain, every future /verify returns "revoked", pharmacists and patients are protected immediately.
High-value biologics, vaccines, specialty Rx. Serial-level DPP plus cold-chain integrity proof via IoT sensor ingestion.
High-volume, low-margin — Fidaty's bulk-issue APIs mint thousands of DPPs per minute without driving gas cost up.
Goods-in scans feed custody acceptance; inventory auto-updated. Dispensing triggers the patient-facing DPP (where permitted).
Every movement recorded as a custody event. GDP audits pre-validated; insurance premiums reduced on proven chain integrity.
Every service in the Fidaty platform is integrated with the rest: identity, compliance, analytics and consumer engagement flow seamlessly. No data silos, no duplicate work.
Book a demoFMD compliance is the floor; chain-of-custody and diversion detection are the value. Fidaty's pharma template adds both without disrupting EMVS or FMD workflows.